Generic Name and Formulations:
Rifaximin 550mg; tabs.

Company:
Salix Pharmaceuticals, Inc.
Indications for XIFAXAN 550mg:
Reduction in risk of overt hepatic encephalopathy recurrence in patients ≥18yrs of age.

Adult Dose for XIFAXAN 550mg:
≥18yrs: 550mg twice daily.

Children's Dose for XIFAXAN 550mg:
<18yrs: not recommended.

Pharmacological Class:
Rifamycin.

Warnings/Precautions:
Not studied in patients with MELD scores >25; only 8.6% of patients in the controlled trial had MELD >19. Increased systemic exposure in patients with more severe hepatic dysfunction; caution should be exercised in patients with severe hepatic impairment (Child-Pugh C). Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.

Adverse Reactions:
Peripheral edema, nausea, dizziness, fatigue, ascites.

How Supplied:
Tabs—60